Cargando…

The current status and future directions of myxoma virus, a master in immune evasion

Myxoma virus (MYXV) gained importance throughout the twentieth century because of the use of the highly virulent Standard Laboratory Strain (SLS) by the Australian government in the attempt to control the feral Australian population of Oryctolagus cuniculus (European rabbit) and the subsequent illeg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spiesschaert, Bart, McFadden, Grant, Hermans, Katleen, Nauwynck, Hans, Van de Walle, Gerlinde R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131250/ https://www.ncbi.nlm.nih.gov/pubmed/21658227 http://dx.doi.org/10.1186/1297-9716-42-76

Ejemplares similares

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways
por: Rahman, Masmudur M., et al.
Publicado: (2020)

The Myxoma Poxvirus Protein, M11L, Prevents Apoptosis by Direct Interaction with the Mitochondrial Permeability Transition Pore
por: Everett, Helen, et al.
Publicado: (2002)

Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-Induced Antiviral State in a Highly Species-Specific Fashion
por: Rahman, Masmudur M., et al.
Publicado: (2017)

Immune evasion in acute myeloid leukemia: current concepts and future directions
por: Teague, Ryan M, et al.
Publicado: (2013)

Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells
por: Rahman, Masmudur M., et al.
Publicado: (2017)

The α2,3-Sialyltransferase Encoded by Myxoma Virus Is a Virulence Factor that Contributes to Immunosuppression
por: Boutard, Bérengère, et al.
Publicado: (2015)

Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells
por: Bartee, Eric, et al.
Publicado: (2012)

Co-Regulation of NF-κB and Inflammasome-Mediated Inflammatory Responses by Myxoma Virus Pyrin Domain-Containing Protein M013
por: Rahman, Masmudur M., et al.
Publicado: (2009)

Genetic Characterization of a Recombinant Myxoma Virus in the Iberian Hare (Lepus granatensis)
por: Águeda-Pinto, Ana, et al.
Publicado: (2019)

NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy
por: Cornejo, Yvonne, et al.
Publicado: (2020)

Coinfections of Novel Polyomavirus, Anelloviruses and a Recombinant Strain of Myxoma Virus-MYXV-Tol Identified in Iberian Hares
por: Águeda-Pinto, Ana, et al.
Publicado: (2020)

M11l: A Novel Mitochondria-Localized Protein of Myxoma Virus That Blocks Apoptosis of Infected Leukocytes
por: Everett, Helen, et al.
Publicado: (2000)

The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase
por: Woo, Yanghee, et al.
Publicado: (2021)

Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
por: Jazowiecka-Rakus, Joanna, et al.
Publicado: (2020)

Myxoma Virus Protein M029 Is a Dual Function Immunomodulator that Inhibits PKR and Also Conscripts RHA/DHX9 to Promote Expanded Host Tropism and Viral Replication
por: Rahman, Masmudur M., et al.
Publicado: (2013)

Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
por: Jazowiecka-Rakus, Joanna, et al.
Publicado: (2022)

Interleukin-15 (IL-15) and IL-15 receptor alpha fusion protein enhances antitumor activity of myxoma virus
por: Tosic, Vesna, et al.
Publicado: (2013)

RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells
por: Rahman, Masmudur M., et al.
Publicado: (2021)

SARS-CoV-2: A Master of Immune Evasion
por: Rubio-Casillas, Alberto, et al.
Publicado: (2022)

Colletotrichum – current status and future directions
por: Cannon, P.F., et al.
Publicado: (2012)

Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
por: Weng, Mingzhe, et al.
Publicado: (2014)

Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
por: Rahman, Masmudur M., et al.
Publicado: (2023)

Omicron: Master of immune evasion maintains robust ACE2 binding
por: Hoffmann, Markus, et al.
Publicado: (2022)

Network Security: Current Status and Future Directions
por: Douligeris, Christos
Publicado: (2007)

Current status and future directions of personalized medicine
por: Bryce, Alan Haruo, et al.
Publicado: (2013)

Metformin Pharmacogenomics: Current Status and Future Directions
por: Pawlyk, Aaron C., et al.
Publicado: (2014)

Radiation Metabolomics: Current Status and Future Directions
por: Menon, Smrithi S., et al.
Publicado: (2016)

Current Status and Future Directions of Capsule Endoscopy
por: Chun, Hoon Jai, et al.
Publicado: (2016)

Biofilms in Endodontics—Current Status and Future Directions
por: Neelakantan, Prasanna, et al.
Publicado: (2017)

Ultrasonography: current status, challenges, and future directions
por: Choi, Byung Ihn
Publicado: (2018)

PSMA Theranostics: Current Status and Future Directions
por: Rahbar, Kambiz, et al.
Publicado: (2018)

Current status and future directions of cancer immunotherapy
por: Zhang, Hongming, et al.
Publicado: (2018)

Keloid research: current status and future directions
por: Tsai, Chia-Hsuan, et al.
Publicado: (2019)

Honey and Cancer: Current Status and Future Directions
por: Porcza, Laura M., et al.
Publicado: (2016)

The current status and future directions of robotic pancreatectomy
por: Nakata, Kohei, et al.
Publicado: (2021)

Prosthetics in urology: Current status and future directions
por: Cheriyan, Abhilash
Publicado: (2023)

Cardiovascular Biomarkers: Current Status and Future Directions
por: Filipovic, Mark G., et al.
Publicado: (2023)

Hydroxychloroquine in nephrology: current status and future directions
por: Rao, Indu Ramachandra, et al.
Publicado: (2023)

Myxoma Virus Targets Primary Human Leukemic Stem and Progenitor Cells While Sparing Normal Hematopoietic Stem and Progenitor Cells
por: Kim, Manbok, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_l0936h1ter625ct7oe1u16kujj